Hypercoagulability and Vascular Disease

Ali T. Taher, Maria Domenica Cappellini, Rayan Bou-Fakhredin, Daniel Coriu, Khaled M. Musallam

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

The presence of a high incidence of thrombotic events, mainly in nontransfusion-dependent β-thalassemia syndromes, has led to the identification of a hypercoagulable state in thalassemia patients. This article highlights the mechanisms leading to hypercoagulability in thalassemia. It also discusses the clinical experience and available evidence on prevention and management approaches.

Original languageEnglish
Pages (from-to)237-245
Number of pages9
JournalHematology/Oncology Clinics of North America
Volume32
Issue number2
DOIs
Publication statusPublished - Apr 1 2018

Fingerprint

Thalassemia
Thrombophilia
Vascular Diseases
Incidence

Keywords

  • Cerebrovascular disease
  • Hypercoagulable state
  • Pulmonary hypertension
  • Thrombosis

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this

Hypercoagulability and Vascular Disease. / Taher, Ali T.; Cappellini, Maria Domenica; Bou-Fakhredin, Rayan; Coriu, Daniel; Musallam, Khaled M.

In: Hematology/Oncology Clinics of North America, Vol. 32, No. 2, 01.04.2018, p. 237-245.

Research output: Contribution to journalReview article

Taher, AT, Cappellini, MD, Bou-Fakhredin, R, Coriu, D & Musallam, KM 2018, 'Hypercoagulability and Vascular Disease', Hematology/Oncology Clinics of North America, vol. 32, no. 2, pp. 237-245. https://doi.org/10.1016/j.hoc.2017.11.001
Taher, Ali T. ; Cappellini, Maria Domenica ; Bou-Fakhredin, Rayan ; Coriu, Daniel ; Musallam, Khaled M. / Hypercoagulability and Vascular Disease. In: Hematology/Oncology Clinics of North America. 2018 ; Vol. 32, No. 2. pp. 237-245.
@article{d5142ca323fe49c1a2052ab0a2680d7f,
title = "Hypercoagulability and Vascular Disease",
abstract = "The presence of a high incidence of thrombotic events, mainly in nontransfusion-dependent β-thalassemia syndromes, has led to the identification of a hypercoagulable state in thalassemia patients. This article highlights the mechanisms leading to hypercoagulability in thalassemia. It also discusses the clinical experience and available evidence on prevention and management approaches.",
keywords = "Cerebrovascular disease, Hypercoagulable state, Pulmonary hypertension, Thrombosis",
author = "Taher, {Ali T.} and Cappellini, {Maria Domenica} and Rayan Bou-Fakhredin and Daniel Coriu and Musallam, {Khaled M.}",
year = "2018",
month = "4",
day = "1",
doi = "10.1016/j.hoc.2017.11.001",
language = "English",
volume = "32",
pages = "237--245",
journal = "Hematology/Oncology Clinics of North America",
issn = "0889-8588",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Hypercoagulability and Vascular Disease

AU - Taher, Ali T.

AU - Cappellini, Maria Domenica

AU - Bou-Fakhredin, Rayan

AU - Coriu, Daniel

AU - Musallam, Khaled M.

PY - 2018/4/1

Y1 - 2018/4/1

N2 - The presence of a high incidence of thrombotic events, mainly in nontransfusion-dependent β-thalassemia syndromes, has led to the identification of a hypercoagulable state in thalassemia patients. This article highlights the mechanisms leading to hypercoagulability in thalassemia. It also discusses the clinical experience and available evidence on prevention and management approaches.

AB - The presence of a high incidence of thrombotic events, mainly in nontransfusion-dependent β-thalassemia syndromes, has led to the identification of a hypercoagulable state in thalassemia patients. This article highlights the mechanisms leading to hypercoagulability in thalassemia. It also discusses the clinical experience and available evidence on prevention and management approaches.

KW - Cerebrovascular disease

KW - Hypercoagulable state

KW - Pulmonary hypertension

KW - Thrombosis

UR - http://www.scopus.com/inward/record.url?scp=85035226573&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85035226573&partnerID=8YFLogxK

U2 - 10.1016/j.hoc.2017.11.001

DO - 10.1016/j.hoc.2017.11.001

M3 - Review article

AN - SCOPUS:85035226573

VL - 32

SP - 237

EP - 245

JO - Hematology/Oncology Clinics of North America

JF - Hematology/Oncology Clinics of North America

SN - 0889-8588

IS - 2

ER -